Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Infant bones fail to harden most often because of hypophosphatasia (HPP), a rare inherited condition in which low alkaline phosphatase activity blocks mineral from depositing in bone, though rickets from vitamin D or mineral deficiency can cause similar softening. Warning signs in babies include a soft or bulging skull with widely open sutures, bowed or short limbs, poor weight gain, trouble breathing due to a soft rib cage, early loss of baby teeth with the root still attached, unexplained fractures, and low muscle tone or feeding difficulty. Because HPP and rickets look alike but need very different treatment, a doctor will typically check blood alkaline phosphatase, calcium, phosphate, and vitamin D levels, order X-rays of the wrists, knees, and chest, and may confirm with ALPL gene testing before referring to a metabolic bone or genetic specialist. Early diagnosis matters, since enzyme replacement therapy exists for HPP and nutritional rickets often responds quickly to correct supplementation, while delays can worsen breathing problems, deformity, and growth failure. Several factors influence which condition is present and how urgently to act, so see below for the details you should review before your next appointment.
Last reviewed for medical accuracy: 08/18/2026
If your baby shows any of these signs, waiting for answers can feel unbearable, and guessing between HPP, rickets, or something else is not something you should have to do alone. A free, instant, online symptom check can help you organize what you are seeing, understand which findings matter most, and prepare clear questions for your pediatrician so nothing gets missed. It takes only a few minutes, costs nothing, and can help you decide how quickly to seek care and which specialist to ask about next.
When a baby’s bones don’t harden as expected, it can be distressing for parents. One rare but important cause is hypophosphatasia (HPP). Understanding HPP early on can help you get the right care and support for your little one. This guide explains why infant bones fail to harden in HPP, outlines warning signs, and walks you through the steps a doctor may take.
Hypophosphatasia is a genetic condition that affects how bones mineralize and harden. Normally, an enzyme called alkaline phosphatase (ALP) helps build strong bones and teeth by depositing minerals like calcium and phosphate. In babies with HPP, mutations in the ALPL gene reduce ALP activity. As a result, bones remain soft, making them prone to deformities and fractures.
Key points:
Bone mineralization is a delicate process. Here’s how HPP disrupts it:
Together, these factors explain why bones in a hypophosphatasia baby remain flexible and fragile, often leading to bowing of legs, rib cage deformities, and repeated fractures.
Recognizing HPP early can speed up diagnosis and care. Look out for:
If you notice any combination of these signs in your infant, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
A pediatrician or pediatric endocrinologist will confirm HPP through:
Your doctor will discuss results and the type of HPP, from perinatal (most severe) to mild forms. Early diagnosis empowers you to start treatment before complications worsen.
While there’s no cure for HPP, targeted therapies and supportive care can greatly improve a baby’s quality of life.
Facing a rare condition can feel isolating. These resources can help:
Hypophosphatasia in infants can be challenging, but early detection and a comprehensive care plan make a real difference. If you suspect your baby may have HPP or any serious bone condition, speak to a doctor promptly. Your care team can guide you through diagnosis, treatment options, and support services to help your child thrive.
Speak to a doctor about anything that could be life threatening or serious.
(References)
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Mornet E. Hypophosphatasia. Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20. PMID: 28939177.
* Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020 Sep 5;754:144855. doi: 10.1016/j.gene.2020.144855. Epub 2020 Jun 6. PMID: 32522695.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Cianferotti L. Osteomalacia Is Not a Single Disease. Int J Mol Sci. 2022 Nov 28;23(23). doi: 10.3390/ijms232314896. Epub 2022 Nov 28. PMID: 36499221; PMCID: PMC9740398.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.